Background Reduced presynaptic density, commonly referred to as synaptic loss, is an early and clinically relevant feature of parkinsonian disorders. The development of positron emission tomography (PET) radiotracers targeting synaptic vesicle glycoprotein 2A (SV2A) has enabled in vivo quantification of synaptic densit...
Chiara Camastra, Carme Uribe, Angenelle Eve Rosal et al.· Journal of Parkinson's Disea...· 0 citations
Mean blood GFAP concentrations are higher in clinically diagnosed PSP than in healthy controls, although the biological basis and disease specificity of this finding remain uncertain, and GFAP should not be considered a stand-alone diagnostic marker.
G. Magro, Vincenzo Laterza, A. Mechelli et al.· Journal of Neurological Scie...· 0 citations
It is demonstrated that the brain networks associated with RBD, depression and anxiety non-motor symptoms were largely overlapping, involved the attention networks and were spatially aligned with the noradrenergic system, suggesting that these symptoms may have shared neurobiological substrates.
Chiara Camastra, Aldo Quattrone, A. Quattrone· Brain Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.